Type 2 inflammation in asthma — present in most, absent in many
作者： John V. Fahy
DOI: 10.1038/NRI3786
关键词:
摘要: … To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we …
nature.com
sci-hub.se 参考文章(79)
Ashwini P. Reddy, Meera R. Gupta, Management of asthma: the current US and European guidelines. Advances in Experimental Medicine and Biology. ,vol. 795, pp. 81- 103 ,(2014) , 10.1007/978-1-4614-8603-9_6
Sharon Croisant, Epidemiology of Asthma: Prevalence and Burden of Disease Advances in Experimental Medicine and Biology. ,vol. 795, pp. 17- 29 ,(2014) , 10.1007/978-1-4614-8603-9_2
Peter Hodsman, Claire Ashman, Anthony Cahn, Erika De Boever, Nicholas Locantore, Adrian Serone, Isabelle Pouliquen, A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics British Journal of Clinical Pharmacology. ,vol. 75, pp. 118- 128 ,(2013) , 10.1111/J.1365-2125.2012.04334.X
RD May, PD Monk, ES Cohen, D Manuel, F Dempsey, NHE Davis, AJ Dodd, DJ Corkill, J Woods, C Joberty-Candotti, LA Conroy, F Koentgen, EC Martin, R Wilson, N Brennan, J Powell, IK Anderson, Preclinical development of CAT‐354, an IL‐13 neutralizing antibody, for the treatment of severe uncontrolled asthma British Journal of Pharmacology. ,vol. 166, pp. 177- 193 ,(2012) , 10.1111/J.1476-5381.2011.01659.X
Mario Castro, Sameer Mathur, Frederick Hargreave, Louis-Philippe Boulet, Fang Xie, James Young, H. Jeffrey Wilkins, Timothy Henkel, Parameswaran Nair, Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study American Journal of Respiratory and Critical Care Medicine. ,vol. 184, pp. 1125- 1132 ,(2011) , 10.1164/RCCM.201103-0396OC
Maeve A. McArdle, Orla M. Finucane, Ruth M. Connaughton, Aoibheann M. McMorrow, Helen M. Roche, Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies Frontiers in Endocrinology. ,vol. 4, pp. 52- 52 ,(2013) , 10.3389/FENDO.2013.00052
M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'brien, H. Fox, J. Thirlwell, N. Gupta, G. Della Cioppa, The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics European Respiratory Journal. ,vol. 18, pp. 254- 261 ,(2001) , 10.1183/09031936.01.00092101
Salman Siddiqui, Amanda Sutcliffe, Aarti Shikotra, Lucy Woodman, Camille Doe, Sue McKenna, Andrew Wardlaw, Peter Bradding, Ian Pavord, Christopher Brightling, Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis The Journal of Allergy and Clinical Immunology. ,vol. 120, pp. 813- 819 ,(2007) , 10.1016/J.JACI.2007.05.028
Francis Davoine, Min Cao, Yingqi Wu, Farnam Ajamian, Ramses Ilarraza, Andy I. Kokaji, Redwan Moqbel, Darryl J. Adamko, Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. The Journal of Allergy and Clinical Immunology. ,vol. 122, pp. 69- 77 ,(2008) , 10.1016/J.JACI.2008.03.028
Mark C. Siracusa, Steven A. Saenz, Elia D. Tait Wojno, Brian S. Kim, Lisa C. Osborne, Carly G. Ziegler, Alain J. Benitez, Kathryn R. Ruymann, Donna L. Farber, Patrick M. Sleiman, Hakon Hakonarson, Antonella Cianferoni, Mei-Lun Wang, Jonathan M. Spergel, Michael R. Comeau, David Artis, Thymic Stromal Lymphopoietin-Mediated Extramedullary Hematopoiesis Promotes Allergic Inflammation Immunity. ,vol. 39, pp. 1158- 1170 ,(2013) , 10.1016/J.IMMUNI.2013.09.016